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Abstract
Cardiovascular disease (CVD) is a group of disease that involve the cardiovascular system. 
According to World Health Organization, it is the leading cause of death worldwide and 
hypertension is a major risk factor of CVD. Pregnancy is a special “window” for women and 
the physiological change could reflect enduring risk for CVD. In a recent study, researchers 
were interested in whether placental malperfusion could predict risk of CVD 8-10 years after 
delivery, and blood pressure (BP) is one of the endpoints of interest. In this thesis, we 
studied whether placental malperfusion is predictive for elevated BP. BP was repeatedly 
measured for three times during the office visit, thus the data had a longitudinal structure. 
One challenge is that BP fluctuates with regards to time during a day, and it is essential to 
adjust for the potential confounding effect of time in regression analyses. Splines provide a 
powerful tool to adjust for such relationship with abundant flexibility. In this thesis, nat-
ural cubic splines (NCS) and smoothing splines (SS) were considered and compared. As a 
consequence, application of the splines could identify significant predictive biomarkers, with 
flexible adjustment of the time effect. NCS is easier to use while SS is more flexibile. 
Public health importance: Limited number of research have been done about the prog-
nostic utility of placental malperfusion on risk of hypertension and CVD. Splines provide a 
powerful and flexible tool to characterize such a relationship.
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1.0 Introduction
Cardiovascular disease is a life-course disease which involves the heart and blood vessels
in human bodies, and the common types of CVD includes coronary heart disease, cerebrovas-
cular disease, peripheral arterial disease and rheumatic heart disease.[1] CVD is the major
cause of death in the United States, accounting for more than 28.8 percent of the total death
in 2017.[2] The risk of CVD starts accumulating since the early stage of adulthood, and often
relates to the onset of CVD later in life.[3] For women, pregnancy is a unique ”window” to
go through a ‘stress test’ of the cardiovascular system and has the potential CVD risk factors
manifest in their early stage of life.[4]
Hypertension is a common and serious medical condition characterized by elevated blood
pressure (BP) measurements.[1] According to the 2017 Guideline for the Prevention, Detec-
tion, Evaluation, and Management of High Blood Pressure in Adults by American College of
Cardiology, hypertension is diagnosed by the systolic blood pressure (SBP) measurement be-
ing ≥ 130 mmHg or the diastolic blood pressure (DBP) measurement being ≥ 80 mmHg.[5]
Hypertension is one of the most important risk factors for CVD, and approximately half
of the coronary heart disease and stroke cases are related to high BP.[6] Because BP is an
important factor affecting the health of one’s cardiovascular system, it is critical to detect
hypertension early and treat accordingly. However, as much as 38% of hypertension cases
were undetected before the age of 40.[7]
In a recent window study initiated in Magee-Womens Hospital in Pittsburgh, PA, 499
women were selected from an retrospective cohort of pregnant women with deliveries at the
Magee-Womens Hospital in 2008 or 2009. The primary objective of this study is to identify
clinical biomarkers that predict the risk of CVD. A primary endpoint is the BP measured at
clinic visits, and the primary biomarker of interest is placental malperfusion. The research
subjects’ BP were measured at their clinical office visit about 8-10 years after their index
delivery, with a standardized manner by trained research staff. The BP were measured after
a five-minute rest, and were measured for three times on the non-dominant arm using an
appropriately sized cuff with one-minute intervals between each adjacent measurements.
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The research subjects’ placental pathology were extracted from an existing dataset, as
well as other clinical features such as BMI at pregnancy, preeclampsia, age and family his-
tory of heart disease. Placental malperfusion, referred to poor placental perfusion, has
the main pathological characteristics as decidual vasculopathy, infarcts, abruption and ad-
vanced villous maturation.[8] It is known that placental malperfusion has well-established
associations with adverse pregnancy outcomes (APO) such as preeclampsia, growth re-
striction and preterm delivery, and APO is related to increased risk for future CVD in
women.[9, 10, 11, 12, 13] In this study, it was proposed that the pathological impairments
converge in the placenta to make the placental malperfusion a common pathway to mul-
tiple APOs, and thus a consequential, unifying feature that links APOs to maternal car-
diometabolic and microvascular risk after delivery.
The placenta malperfusion lesions were determined by both gross and microscopic pla-
cental pathology findings following a uniform consensus criteria described in the Amster-
dam Placental Workshop Group Consensus Statement.[14] The gross findings are placental
hypoplasia, infarction, and retroplacental hemorrhage and the microscopic findings are ab-
normalities of villous development, which includes distal villous hypoplasia and accelerated
villous maturation. In this research, the evidence of malperfusion lesions were grouped in five
domains including vasculaopathy, advanced villious maturation, infarction, fibrin deposition
and perivillous fibrin, and marked as one union factor called “malperfusion”.
One of the challenges in the study of BP is that BP fluctuates during the day and has a
strong circadian pattern.[15] For each person, BP measurements are not constant during the
day, thus the measurement time should be adjusted to account for potential confoundings.
Splines is a powerful tool to provide a flexible adjustment for the fluctuating pattern. It fits
multiple functional forms for each specified or default time intervals. Therefore it could fit
very flexible curves according to the time range.
Natural cubic spline (NCS) is a widely used tool to provide a flexible fit between a contin-
uous predictor and the continuous outcome. It is specially useful when such a relationship is
not the primary concern of the study, but it is necessary to be adjusted for the data analysis.
To implement NCS, polynomial curves which are continuous up to the second derivatives
are fitted in each pre-defined time intervals. Basically, it is a piecewise smooth curve with
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different functional forms on each interval and continuous at the knots (boundary of the
intervals), and will provide a more flexible fit than a regular polynomial regression.
Smoothing spline (SS) is a more general spline method than NCS. Instead of fitting the
relationship in regard to specific knots, it will fit the curves according to all time points. It
is more flexible, and penalizes both the bias and roughness of the fitted curve. However, it
is more difficult to program and implement in practice.
The objective of this thesis is to describe the difference of the 8-10 years postpartum BP
measurements between woman with placental evidence of maternal malperfusion and those
without such lesions during pregnancy and determine whether women with those lesions
have excess risk of hypertension.
There are two challenges in the analysis of BP data in the window study. First, each
research subject had three repeated measurements, thus the data structure is longitudinal.
Second, there is wide variation in time when those measurements were taken. In our data,
the office visit time ranged from to 06:53am to 15:34pm, and the comparison of BP should
adjust for the measurement time. Based on the data structure and research question, we
incorporated NCS and SS in the mixed-effect models separately and compared the results.
In Chapter 2, we will give a more detailed review of the two spline methods. In Chapter
3 we will describe the dataset and apply spline-based methods. We conclude with discussion
in Chapter 4.
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2.0 Methods
2.1 Non-Parametric Regression Models
Linear regression is one of the most commonly used techniques to model the relation-
ship between the outcome variable y and the predictors {x1, x2, ..., xp}.[16] The model is
characterized by
yi = β0 + β1x1,i + ...+ βpxp,i + i, i = 1, 2, ..., n
where β0 is the intercept, {β1, ..., βn} are regression coefficients corresponding to predictors
{x1, ..., xp} and i is the residual term. Given the observed data, one could fit the linear
regression model and use the model to predict outcomes for new observations. Typically,
linear regression has the assumption of linear relationship, independent of residuals and
equal variance of residuals (homoscedasticity). The model is fitted with least square, which
estimates by minimizing residual sum of square
∑n
i=1{yi−β0−β1x1,i− ...−βpxp,i}2. Linear
regression is easy to fit and interpret, in average, y would increase by β1 with each unit
increase in x1 and other covariates fixed. However, linear regression is not very flexible and
could only model linear relationship.
In reality, there are many occasions that the relationship between the outcome variable
and the predictors are obviously non-linear. Then, polynomial regression model is more
appropriate. Given data points {yi, ti, i = 1, 2, ..., n}, the model has the form
yi = g(ti) + , i = 1, 2, ..., n
where g(t) is a polynomial function of t. In practice, it is essential to consider both the
goodness-of-fit and the roughness of the curve. The goodness-of-fit of a curve is measured by
the residual sum of square
∑n
i=1{Yi−g(ti)}2. The roughness of a curve defined on an interval
[a, b] can be measured by the second derivative g′′(t) if the curve is twice differentiable, and
the absolute value of g′′ indicates the degree of fluctuation. Therefore, the integrated squared
second derivative
∫ b
a
{g′′(t)}2 dt is a global measure of roughness, which has computational
advantages compared to
∫ b
a
|g′′(t)| dt. In order to balance between the residual sum of squares
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and the roughness of the fitted curve, a roughness penalty approach is introduced. Given a
smoothing parameter α > 0, the penalized sum of squares is defined as
S(g) =
n∑
i=1
{Yi − g(ti)}2 + λ
∫ b
a
{g′′(t)}2 dt.
where λ is the smoothing parameter. The penalized least squares estimator is the curve
function gˆ that minimizes the penalized sum of squares function S(g) for a fixed λ. Compared
to least square estimator, the penalized least squares estimator takes both the goodness-of-fit
of the data and the roughness of the curve into consideration. As λ goes to zero, the penalty
term in penalized least square goes to zero, thus the fitted curve would be interpolating every
data point and could overfit a new dataset. As λ goes to infinity, the penalty term is the
dominating part of the penalized least squares and it would force the roughness term to be
zero, thus the curve would become a linear regression fit but there would be a poor fit for
the data. Such a nonparametric regression model could provide a flexible description on the
association between the outcome and predictors.
2.2 Natural Cubic Splines
Compared to regression models, spline functions are more flexible to model this relation-
ship. In this section, we will describe natural cubic splines with more details.
Given knots t1, t2, ..., tn on an interval [a,b], such that a < t1 < t2 < ... < tn < b, a curve
function g(t) defined on [a, b] is a cubic spline if it satisfies two conditions.
(i) g(t) is a cubic polynomial on each interval (a, t1), (t1, t2), ..., (tn, b).
(ii) The function and its first and second derivatives are continuous at each knot ti, so
that the polynomial pieces of g(t) fit together at the knots ti.
A cubic spline defined on [a, b] is said to be a natural cubic spline if its second and third
derivatives at a and b are zero. This means that g(t) is linear on the intervals [a, t1] and
[tn, b].
It is natural to express the natural cubic spline defined on [a, b] as
g(t) = di(t− ti)3 + ci(t− ti)2 + bi(t− ti) + ai for ti ≤ t ≤ ti+1, i = 0, 1, ..., n (2.1)
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and we define t0 = a and tn+1 = b. Because of the continuity of g(t) and its first two
derivatives at internal knots, there are restrictions among the coefficients {ai, bi, ci, di}, and
such representation is redundant in practice.
The value-second derivative representation provide a more convenient way to specify a
NCS with the value g(ti) and the second derivative g
′′
(ti) at each knots.[17] Let gi = g(ti) be
the NCS on interval [a, b] with fixed knots ti, i = 1, ..., n such that a < t1 < t2 < ... < tn < b.
Define gi = g(ti) and γi = g
′′
(ti). From the property of NCS we know that γ1 = γi = 0.
Define two matrix g and γ as g = [g1, g2, ..., gn]
T and γ = [γ2, γ2, ..., γn−1]T . Then we can
define the n× (n− 2) matrix Q and the (n− 2)× (n− 2) matrix R. Let hi = ti+1 − ti for i
= 1,...,n-1, then matrix Q is constructed as
qj−1,j = h−1j−1, qj,j = h
−1
j−1 − h−1j and qj+1,j = h−1j j = 2, ..., n− 1
and qi,j = 0 for |i− j| ≥ 2.
R is a symmetric matrix constructed with elements ri,j:
ri,i =
1
3
(hi−1 + hi) for i = 2, ..., n− 1,
ri,i+1 = ri=1,i =
1
6
hi for i = 2, ..., n− 1,
and ri,j = 0 for |i− j| ≥ 2
By theorem, a NCS can be specified if and only if the relationship QTg = Rγ is
satisfied.[17] Let g be the cubic curve on interval [tL, tR], and define g(tL) = gL, g(tR) = gR,
g
′′
(t+L) = γL, g
′′
(t−R) = γR, h = tR − tL. Then we have
g
′′
(t) =
(t− tL)γR + (tR − t)γL
h
g
′′′
(t) =
γR − γL
h
because g
′′
(t) is linear and g
′′′
(t) is constant on the interval.
By taking integration with respect to t and plugging in the expressions g(tL) = gL,
g(tR) = gR, we have the expression of g as:
g(t) =
(t− tL)gR + (tR − t)gL
h
− 1
6
(t− tL)(tR − t){(1 + t− tL
h
)γR + (1 +
tR − t
h
)γL} (2.2)
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This representation has the same form as in (2.1). Given the condition that QTg = Rγ,
γ can be obtained as
γ = R−1QTg
Thus, all the parameters in (2.2) can be obtained from the observed data. Consequently,
the value of the NCS at ant point t can be expressed with matrix g and γ.
In order to illustrate the application of NCS in practice, we provide an example R code.
Suppose given a dataset called “data.office”, SBP measure is named “sbp mmhg” and the
corresponding measurement time is named “bp time”. We could fit a NCS between SBP
and time using the code below.
>z . s <− ns ( data . o f f i c e $bp t ime ,
knots=times ( c ( ‘ 0 8 : 3 6 ’ , ‘ 1 0 : 2 2 ’ , ‘ 1 2 : 0 5 ’ , ‘ 1 3 : 5 2 ’ ) ) ,
Boundary . knots = times ( c ( ‘ 0 6 : 5 4 ’ , ‘ 1 5 : 3 2 ’ ) ) )
>NCS1 <− lm(sbp mmhg ˜ z . s , data = data . o f f i c e )
The function “ns()” is used to generate the basis matrix for the NCS with respect to
the measurement time in the dataset. The interval is set to be 06:54am and 15:32pm and
the internal knots are selected to be 08:51am, 10:20am, 12:02pm and 13:43pm. The basis
matrix is stored in the object “z.s”, and one can directly apply the basis matrix to a linear
model to fit the NCS between SBP and the measurement time. The fitted NCS model was
stored in the object “NCS1” and can be further applied into other statistical models such as
mixed-effects model.
2.3 Smoothing Splines
Compared to fitting polynomial curves with NCS, smoothing splines is a more gen-
eral method to estimate the relationship. In this section, we describe a method developed
by Yuedong Wang (2011) to model smoothing splines based on reproducing kernel Hilbert
space.[18]
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2.3.1 Reproducing Kernel Hilbert Space (RKHS)
On a linear space E, a nonnegative function || · || is called a norm if it satisfies
(i)||f || = 0 only when f = 0;
(ii)||αf || = |α| · ||f ||;
(iii)||f + g|| ≤ ||f ||+ ||g||;
And an inner product is a mapping (·, ·): E × E → R which satisfies
(i)(f, g) = (g, f);
(ii)(αf + βg, h) = α(f, h) + β(g, h);
(iii)(f, f) ≥ 0 and (f, f) = 0 only when f = 0;
Thus, a norm could be defined by an inner product as ||f || , √(f, f), and an linear
space together with an inner product is called an inner product space.
If every Cauchy sequence in the space E converges to an element in E, then the space
E is called complete. A Hilbert space (H) is a complete inner product space defined by the
norm.
The most common example of a Hilbert space is a Euclidean space of three dimensions
(R3) with an inner product defined as
x1
x2
x3
 ·

y1
y2
y3
 = x1y1 + x2y2 + x3y3
The inner product satisfies the three properties above, and a norm can be defined ac-
cordingly as ||x|| = √x · x. Given the completeness of Euclidean space, the Euclidean space
with an inner product is a complete inner product space, thus is a Hilbert space.
Let H denote a Hilbert space and the elements of H are real-valued functions f : X →
R, where X is an random set. For any fixed x ∈ X , define
Lx(f) , f(x), f ∈ H,
then Lx: H → R is called the evaluational functional. A Hilbert space is called a repro-
ducing kernel Hilbert space(RKHS) if every evaluational functional Lx is continuous. Lx is
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continuous when Lxfn = fn(x) → f(x) = Lxf
Apply the Riesz representation theorem, there exists an unique Rx ∈ H such that
Lx(f) = (Rx, f)
Thus, Rx itself is function: X → R. Define Rx(Z) as a bivariate function of x and z such
that R(x, z) , Rx(z), x, z ∈ X . Here, the bivariate function R(x, z) is called the reproducing
kernel of the RKHS H. It can be proven that the reproducing kernel is nonnegative definite:
R(x, z) = Rx(z) = Lx(Rz) = (Rx, Rz) ≥ 0
For any α1, ..., αn ∈ R and x1, ..., xn ∈ X ,
n∑
i,j=1
αiαjR(xi, xj) = R(
n∑
i=1
αixi,
n∑
j=1
αjxj) ≥ 0
Thus, for any x1, ..., xn, the matrix |R(xi, xj)|n×n is nonnegative definite.
Denote S as a subspace of a Hilbert space H, then the subspace S is a Hilbert space if S is
closed. The orthogonal complement of can be defined:
S⊥ , {f ∈ H : (f, g) = 0 for all g ∈ S}
Thus for all elements f ∈ H, f can be decomposed as f = g + h, where g ∈ S and h ∈ S⊥.
Meanwhile, H is decomposed as H = S⊕S⊥
Suppose H is RKHS and H = H0
⊕H1, then the RK has the property that
R(x, z) = R((x0, x1), (z0, z1)) = R0(x0, z0) +R1(x1, z1)
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2.3.2 RKHS for Smoothing Spline
Consider the general smoothing spline regression(SSR) model
yi = f(xi) + i, i = 1, ..., n
where yi is the observation of the function f given the covariates xi, and i is the independent
random error with mean zero and variance σ2. f is the functional form of the smoothing
spline. The Sobolev space is defined as:
Wm2 [a, b] = {f : f, f
′
, ..., f (m−1) are absolutely continuous,
∫ b
a
(f (m))2dx ≤ ∞}
If the smoothing spline f has a domain of X = [a, b], and f ∈ Wm2 [a, b], then the the
smoothing spline estimate fˆ ∈ Wm2 [a, b] is the solution to the penalized least squares(PLS):
1
n
n∑
i=1
(yi − f(xi))2 + λ
∫ b
a
(f (m)(x))2dx (2.3)
The Sobolev space Wm2 [a, b] is an RKHS H and one can define an inner product as
(f, g) =
m−1∑
ν=0
f (ν)(a)g(ν)(a) +
∫ b
a
f (m)(x)g(m)(x)dx
Define a decomposition of Wm2 [a, b] as W
m
2 [a, b] = H = H0
⊕H1, where H0 is the subspace
of all the (m-1) order polynomials and H1 contains the orthonormal complement of H0.
H0 = span{1, (x− a), ..., (x− a)(m−1)/(m− 1)!}
H1 = span{f : f (ν)(a) = 0, ν = 0, ...,m− 1,
∫ b
a
(f (m))2dx <∞}
Thus, the corresponding RKs of the RKHS Wm2 [a, b] = H = H0
⊕H1 are
R0(x, z) =
m∑
ν=1
(x− a)(ν−1)
(ν − 1)!
(z − a)(ν−1)
(ν − 1)!
R1(x, z) =
∫ b
a
(x− u)(m−1)+
(m− 1)!
(z − u)(m−1)+
(m− 1)! du
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Here, (x)+ = max{x, 0}. Denote P1 as the orthogonal projection from a function onto H.
For any f ∈ H, f can be decomposed as f = f0 + f1, where f0 ∈ H0, f1 ∈ H1. Thus, the
roughness penalty term ca be expressed as∫ b
a
(f (m))2dx = ||f1||2 = ||P1f ||2
The PLS in (2.3) can be written as:
1
n
n∑
i=1
(yi − f(xi))2 + λ||P1f ||2 (2.4)
There is no penalty applied to functions is f0. The example of polynomial splines suggests
that RHKS could be used to construct the more general smoothing spline with the following
conditions:
(i)The model space of f is an RKHS H;
(ii)The model space can be decomposed as H = H0
⊕H1, where functions f0 ∈ H0 are not
penalized;
(iii)A penalty term as λ||P1f ||2.
2.3.3 Application in General Smoothing Splines
A more general SSR model is that
yi = Lif + i, i = 1, ..., n
where Li are bounded linear functions that Li ∈ H. This is useful when the observation of
f(x) is made through linear functions of f(x), such as f
′
(xi). (2.) is a special case of (2.)
where Li is the evaluational fuctionals at design points(covariates) such that Lif = f(xi).
Li is are bounded according to the definition of RKHS.
In the more general smoothing spline model, the estimate of f , denoted as fˆ , minimizes the
PLS in a form as
1
n
n∑
i=1
(yi − Lf)2 + λ||P1f ||2
The domain of f is an arbitrary set X and the model space is an RKHS H on X with RK
R(x, z), which can be decomposed as H = H0
⊕H1. Equivalently, the function can be
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decomposed as f = f0 + f1. The subspace H0 is a finite dimensional space, and its basis
functions are consisted of {φν(x), ν = 1, ..., p}. H0 is usually called the null space because
the functions f0 ∈ H0 are not penalized. Separately, f0 and f1 are the projection of f onto
H0 and H1. Thus, the magnitude of f1 can be measured with ||P1f ||, which represents the
departure from the null space and can be used to assess the appropriateness of the model.
And λ is used to trade off between the goodness of fit and the appropriateness of the model.
Applying the Riesz representation theorem, there exists a unique representer ηi ∈ H =
Wm2 [a, b] such that
Lif = f(xi) = (ηi, f)
ηi(x) = (ηi, Rx) = LiRx = Li(z)R1(x, z)
Li(z) is the evaluation functional at xi applied to a function of z.
Let ξi = P1ηi, then ξi is the projection of ηi onto H1. It can be proved that P1 is self-adjoint
that
(P1g, h) = (P1g, P1h+ {h− P1h}) = (P1g, P1h) = (P1g + {g − P1g}) = (g, h)
Given R(x, z) = R0(x, z) +R1(x, z), it can be shown that
ξi(x) = (ξi, Rx) = (P1ηi, Rx) = (ηi, P1Rx) = Li(z)R1(x, z)
Thus, the projection of the representer ηi onto H1, ξi, can be calculated by applying the
operator Li(z) to R1. The inner product of ξ is defined as
(ξi, ξi) = Li(x)ξj(x) = Li(x)Lj(z)R1(x, z)
Recall that {φν(x), ν = 1, ..., p} is the basis function for H0 where there is no penalty, define
T as a n× p matrix and Σ as a n× n matrix that
T = {Liφν}n pi=1 ν=1
Σ = {Li(x)Lj(z)R1(x, z)}ni,j=1
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Then, assume that
fˆ(x) =
p∑
ν=1
dνφν(x) +
n∑
i=1
ciξi(x) + ρ
where ρ ∈ H1, and (ρ, ξi) = 0 for i = 1,...,n.
∑p
ν=1 dνφν(x) is the projection of fˆ onto
H0, denoted as P0f .
∑n
i=1 ciξi(x) is the projection of P1fˆ onto the subspace spanned by
{ξi(x), i = 1, ..., n}. Recall that ξi = P1ηi ∈ H1, then ζi = ηi − ξi ∈ H0. ζi and ξi are the
projection of the unique representer ηi ∈ H onto H0 and H1, respectively. Therefore,
Liρ = (ηi, ρ) = (ξi, ρ) + (ζi, ρ) = 0 + 0 = 0
Denote y = (y1, ..., yn)
T and fˆ = (L1fˆ , ...,Lnfˆ)T respectively as the observation vector and
fitted value vector. Let d = (d1, ..., dp)
T and c = (c1, ..., cp)
T , then we have
fˆ = Td+ Σc
In addition, ||P1f ||2 = ||
∑n
i=1 ciξi + ρ||2 = cTΣc + ||ρ||2. Hence, the PLS can be reformed
as
1
n
||y − Td− Σc||2 + λ(cTΣc+ ||ρ||2)
Thus, the PLS is minimized only when ρ = 0.
The Kimeldorf-Wahba representer theorem is: Given T is of full column rank. Then the
PLS in (2.4) has a unique minimized from[19]
fˆ(x) =
p∑
ν=1
dνφν(x) +
n∑
i=1
ciξi(x)
At ρ = 0, the PLS term is
1
n
||y − Td− Σc||2 + λcTΣc
where c and d are coefficients that needed to be estimated from the observed data. Apply
QR decomposition to T , we have T =
(
Q1 Q2
)(
R
0
)
, where (Q1, Q2) is an orthogonal matrix
and Q1, Q2 are respectively n×p, n×(n−p) matrices, and R is an upper triangular invertible
p× p matrix.
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Define M = Σ + nλI, it can be shown that the PLS has a solution that the fitted values
fˆ has a form
fˆ = Td+ σc = y − nλc = H(λ)y
where
H(λ) , I − nλQ2(QT2MQ2)−1QT2
Computing details are given in the book. It is proved that given the observation (xi, yi)
T , i =
1, ..., n, the fitted values yˆ could be calculated with a specified λ.
2.3.4 Linear Mixed-Effects Model
Linear mixed-effects model is an extension of linear regression model, with both fixed
effects and random effects included.[20] When the outcome is repeatedly measured within
each research subject, it is not proper to assume the observations are independent with other,
and the data has a longitudinal structure and a mixed-effects model should be fitted. Fixed
effect is the variation that is explained by independent predictors, and random effect is the
variation not explained by the predictors. For example, when studying the effect of placental
malperfusion on repeatedly measured BPs, the variation due to placental malperfusion is
fixed effects and the variation within each research subject is random effect. The linear
mixed-effects model has a form
yi = X iβ +Zibi + i, i = 1, 2, ..., n
where y is the vector of continuous outcome, X are the design matrix, β is the vector of
fixed effects, Z is the matrix of covariates, b is the vector of random effects and  is the
vector of residuals. For example, X contains the value of placental malperfusion and Z is
the matrix of subject indicators. It is assumed that bi and i follow normal distribution
with mean zero and variance of matrix D and Ri, respectively. The random effects bi are
independent with the residual error i for the same subject.
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2.3.5 Semiparametric Mixed-Effects Models
In the motivating dataset of our study, the outcome variable is the three repeatedly
measured BP for each women. For each measurement, both the systolic blood pressure
(SBP) and diastolic blood pressure (DBP) were recorded as well as the measurement time.
For each women, the covariate of primary interest is “placental malperfusion” which is a
binary variable coded as 0 or 1, with 1 representing women with placental malperfusion
and 0 representing women without placental malperfusion. Other binary covariates includes
“preeclampsia” (1 for cases and 0 for non-cases), “race” (1 for black and 0 for others),
“family history of hypertension” (1 for cases and 0 for non-cases) and “family history of
heart disease” (1 for cases and 0 for non-cases). There are two continuous variables, “age”
and “body mass index (BMI) at pregnancy”.
For our repeatedly measured data, the semiparametric linear mixed-effects models has
the form as
yij = S
T
ijβ + Lijf + zTijbi + ij, i = 1, 2, ...,m; j = 1, ..., ni,
where yij (i = 1, ..., n and j = 1, 2, 3) represents the jth BP measurements for ith woman.
Here, n is number of subjects in the dataset. β is the coefficient vector of the fixed effects
and bi ∼ N (0,D) are the random effects and D is the covariance matrix. In our data, the
fixed effects are the covariates, and the random effects are the variation of baseline between
each women. Lijf = f(tij) is the smoothing spline function in regards to the time points tij.
ij is the random error and i = (i1, ..., ini)
T ∼ N (0, σ2Λi), where Λi = Ini . The PLS can
be further written as
1
n
m∑
i=1
(yi − STi β − Lif)TWi(yi − STi β − Lif) + λ||P1f ||2, n =
m∑
i=1
ni, (2.5)
where W−1 = ZDZT + Λ, Z = diag(Z1, ..., Zm) and Zi = (zi1, ..., zini). The minimizer fˆ(t)
for the PLS(2.5) is
fˆ(t) =
p∑
ν=1
dνφν(t) +
n∑
i=1
Ciξi(t) = Lif
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where {φν(t), ν = 1, ..., p} are the basis functions of H0 with no penalty imposed. And the
PLS term can be reformed as
m∑
i=1
(yi − STi β − T Ti d− ΣTi c)TWi(yi − STi β − T Ti d− ΣTi c) + nλcTΣc
The random effect can be estimated[21] as
bˆ = DZTW (y − Sβ − Td− Σc)
On the other hand, the linear mixed-effects model can be written as
yi = S
T
i β + T
T
i d+ µi + Z
T
i bi + i = Xiα + µi + Z
T
i bi + i (2.6)
where µi ∼ N (0, Σnλ), bi ∼ N (0,D), i ∼ N (0, σ2Ini) and Σ = (R1(ti, tj)). STi β is the fixed
effect, ZTi bi is the random effect and T
T
i d + µi are related to the smoothing splines. This
method could turn the fitted smoothing splines into a form of linear mixed-effect model, and
fitting the linear mixed-effect model is equivalent to fitting the smoothing splines.
2.4 Adopted Models
The purpose of this thesis is to describe the effect of placental malperfusion on maternal
BP 8 to 10 years after delivery, adjusting for other covariates.
At first, the missingness of BP measurements and measurement time was checked, and
only complete cases were included in the final dataset. The distribution of BP measurements
were checked with QQ-plots and the outliers were excluded from the data. Descriptive
statistics were created for the covariates to check if the study design is balanced.
Then, we studied the effects of the covariates on BP without adjusting the measurement
time. Linear mixed-effects model was used to fit the regression model for our longitudinal
data. Two models were fitted step by step to investigate the random effects and fixed effects.
Model I:
Yij = µi + ij
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Here, Yij denotes the jth measurement of blood pressure for the ith subject. µi denotes
the mean blood pressure for the ith subject, which has a normal distribution with mean µ
and variance τ 2, denoted as µi ∼ N (µ, τ 2). µ is the global mean of blood pressure among the
study population and τ 2 is the variation of blood pressure measurements among subjects.
ij is the error term for the jth measurement of blood pressure for the ith subject, which
follows a normal distribution with mean zero and variance σ2, denoted as i ∼ N (0, σ2). σ2
denotes the variation of blood pressure measurements within each subject.
Model II:
Yij = αi + βXi + ij
Here, Xi denotes the covariates of the ith subject fitted in the model and β denotes the
coefficients of the covariates. αi denotes the variation of blood pressure measurements be-
tween each subjects, which has a normal distribution as αi ∼ N (0, τ 2). ij denotes variation
of blood pressure measurements within each subject, which has a normal distribution as i
∼ N (0, σ2).
After that, we used natural cubic spline to adjust for the relationship between BP mea-
surements and measurement time. Then combined the NCS into linear mixed-effects model
to fit the relationship between BP and the covariates of interest, with adjusting for the time.
Model III:
Yij = αi + βXi + g(tij) + ij
with g(tij) representing the NCS.
Lastly, we used smoothing spline to provide a more flexible adjustment for the association
between BP and measurement time. A semiparametric linear mixed-effects model was fitted
as demonstrated in the following.
Model IV:
Yij = αi + βXi + Lf + ij
where Lf = f(tij) represents the smoothing spline term. As illustrated in chapter 2, Model
IV could be fitted by equation (2.6).
In model III and model IV, most of the terms have the same interpretation as in model
II except for the spline term.
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3.0 Data Analysis
3.1 Description of the Data
There were 498 subjects in the original dataset. After excluding subjects with missingness
in their BP measurement times, a total of 367 subjects were included in our study from the
office visit dataset where each subject had 3 repeated measurements of both SBP and DBP
as well as the time for each BP measurement. The normality of the distribution of BP
measures were examined by QQ-plot in R and shown in Figure 1.
Figure 1: QQ Plot Blood Pressure Measures before Excluding Outliers
It is obvious that there were heavy tails in the distribution of both SBP and DBP. After
excluding the outliers (data points outside 1.5 times the interquartile range above the upper
quartile and bellow the lower quartile), there were 351 subjects in our final dataset and the
distribution of the BP measures were very close to normal distribution (Figure 2).
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Figure 2: QQ Plot Blood Pressure Measures after Excluding Outliers
For each subject, the three measurements of BP were performed sequentially in a short
time period, with approximately one minute apart. The measurement times ranged from
06:53am to 15:34pm and the distribution was shown in Figure 3.1 while figure 3.2 shows the
distribution of the measurement time gap for each subject. The time gap was calculated as
the gap between the first measurement and the last measurement for each subject. Most
of the time gaps were smaller than six minutes, thus, for the convenience of our study, the
measurement times of BP were estimated with the mean of the three time records for each
subject.
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(1) Histogram of Blood Pressure Measurement Time
(2) Histogram of Measurement Time Range for Each Subject
Figure 3: Distribution of Blood Pressure Measurement Time
Besides fitting the time trend of BP, we were also interested in the effect of malperfu-
sion, preeclampsia, race (demorace), BMI at pregnancy (prepregbmi), age, family history of
hypertension outside of pregnancy (famhbp) and family history of heart disease (famheart)
on BP and malperfusion was of primary interest. Table 1 summarizes the descriptive statis-
tics for these covariates of interest. The number of records shows how many subjects have
observed data for this covariate.
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Table 1: Descriptive Statistics on Covariates of Interest
Covariates Number of Records (Proportion) Mean (SD) / n (%)
Malperfusion 351 (100%) 117 (33.3%)
Preeclampsia 351 (100%) 45 (12.8%)
Race(black) 351 (100%) 98 (27.9%)
Family History of Hypertension 331(94.3%) 189 (53.8%)
Family History of Heart Disease 305 (86.9%) 72 (20.5%)
BMI at Pregnancy (kg/m2) 247 (70.4%) 26.1 (6.2)
Age (years) 347 (98.9%) 38.0 (6.0)
The Pearson correlation between the three measurements were calculated to examine
the relationship between the three repeated measures(Figure 4). The results showed that
the correlation between the three repeated measurements were exchangeable for both sbp
and dbp, indicating that the order of the measurements does not influence the measurement
result and it was reasonable to treat the three measurement time as an identical one.
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Figure 4: Correlation among Blood Pressure Measurements
3.2 Application of the Linear Mixed-Effects Model
In model I, the variation of blood pressure measurements within each subject was es-
timated to be 49 for sbp and 16 for dbp, and the variation between each subjects had an
estimated value of 121 for sbp and 80 for dbp. From the results, we can tell that the majority
of the variation came from the variation of different subjects, and the repeated measurements
for each subject were consistent.
Table 2 and Table 3 summarized the coefficients, p-values, between subject variations(τ 2)
and within subject variations (σ2) of each univariable models in model II for sbp and dbp
in the office visit data.
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Table 2: Univariable Linear Mixed-Effects Model for SBP
Covariates for Model II Coefficient P-value τ 2 σ2
Malperfusion 0.73 0.58 121.36 49.01
Preeclampsia 7.09 0.0001 115.83 49.01
Race(black) -0.37 0.61 121.36 49.07
Age 0.16 0.13 119.79 49.32
BMI at Pregnancy 0.73 < 0.0001 93.56 51.66
Family History of Hypertension 2.81 0.03 120.55 49.26
Family History of Heart Disease 1.90 0.23 120.94 48.76
Table 3: Univariable Linear Mixed Model for DBP
Covariates for Model II Coefficient P-value τ 2 σ2
Malperfusion 1.77 0.09 79.99 16.22
Preeclampsia 4.39 0.003 78.53 16.22
Race(black) -0.57 0.31 80.61 16.24
Age 0.13 0.11 80.04 15.99
BMI at Pregnancy 0.44 < 0.0001 73.35 15.74
Family History of Hypertension 3.01 0.004 80.62 14.94
Family History of Heart Disease 2.28 0.07 79.28 17.13
It can be noticed that the variation within subjects are smaller than variation between
subjects, and the variation of DBP is much small than SBP. Malperfusion alone was not
significant in predicting either SBP or DBP. Among the covariates of interest, preeclampsia,
BMI at Pregnancy and family history of hypertension were identified to be significant in the
univariable models.
Table 4 and Table 5 summarized the coefficients, p-values, between subject variations
(τ 2) and within subject variations (σ2) of the multivariate models in model II for SBP and
DBP in the office visit data.
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Table 4: Multivariate Mixed-Effects Model for SBP
Covariates for Model II Coefficient P-value τ 2 σ2
Malperfusion 2.08 0.18
96.45 52.32
Preeclampsia 5.61 0.01
Race(black) 2.95 0.12
Age 0.14 0.32
BMI at Pregnancy 0.66 < 0.0001
Family History of Hypertension 0.41 0.80
Family History of Heart Disease 0.25 0.90
Table 5: Multivariate Mixed-Effects Model for DBP
Covariates for Model II Coefficient P-value τ 2 σ2
Malperfusion 2.94 0.02
69.94 15.92
Preeclampsia 2.60 0.13
Race(black) 2.85 0.06
Age 0.16 0.15
BMI at Pregnancy 0.48 < 0.0001
Family History of Hypertension 1.07 0.42
Family History of Heart Disease 2.17 0.17
In the multivariate model, BMI at pregnancy was significant for predicting both SBP
and DBP. Malperfusion was significant in the multivariate model for DBP and preeclampsia
was significant for in the multivariate model for SBP. Women with malperfusion were esti-
mated to have 2.08 (95% CI [-0.98, 5.14]) mmHg higher SBP and 2.94 (95% CI [0.45, 5.43])
mmHg higher DBP than woman without malperfusion lesion. Even though family history of
hypertension and heart disease were pretty significant in the univariable models, they are not
significant in the multivariate model for both SBP and DBP. The between subject variations
were both much greater that the within subject variation of blood pressure measurements.
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3.3 Application of the Mixed-Effects Model with Natural Cubic Splines
In this section, Model III was fitted with five knots for both SBP and DBP, and plotted
in Figure 5.
Figure 5: Natural Cubic Splines Plot for Blood Pressure over the Measurement Time
As shown in the plot, both SBP and DBP appeared to be slightly increased in the
afternoon of a day. However, the time trend of BP was not obvious. To explore the effect of
malperfusion on the time trend of BP, the NCS plots were plotted by different malperfusion
groups.(Figure 6)
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(1) Systolic Blood Pressure
(2) Diastolic Blood Pressure
Figure 6: Natural Cubic Splines Plot of Blood Pressure with Grouping of Malperfusion
For both SBP and DBP, the lines for malperfusion group and non-malperfusion group
were very close to each other in the morning. However, the two lines began to diverge in the
afternoon, and those who had malperfusion during pregnancy had higher BP measurements
than those did not have malperfusion.
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The coefficients, p-values, between subject variations (τ 2) and within subject variations
(σ2) of the full models in Model III for SBP and DBP are summarized in Table 6 and Table
7, respectively.
Table 6: Multivariate Mixed-Effects Model for SBP with NCS
Covariates for Model III Coefficient P-value τ 2 σ2
Malperfusion 1.91 0.23
97.41 52.32
Preeclampsia 5.37 0.01
Race(black) 2.90 0.13
Age 0.16 0.25
BMI at Pregnancy 0.67 < 0.0001
Family History of Hypertension 0.43 0.79
Family History of Heart Disease 0.45 0.82
Table 7: Multivariate Mixed-Effects Model for DBP with NCS
Covariates for Model III Coefficient P-value τ 2 σ2
Malperfusion 3.06 0.02
71.10 15.92
Preeclampsia 2.89 0.10
Race(black) 2.52 0.11
Age 0.17 0.14
BMI at Pregnancy 0.48 < 0.0001
Family History of Hypertension 0.95 0.47
Family History of Heart Disease 2.27 0.16
After adding the NCS to adjust measurement time, there is no remarkable change in
the estimated coefficients and the p-values for each covariates. The variation within and
between each women are also relatively similar with the model without NCS. Women with
placental malperfusion are estimated to have 1.91 (95% CI [-1.20, 5.02]) and 3.06 (95% CI
[0.52, 5.59]) mmhg higher SBP and DBP, respectively.
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3.4 Application of Mixed-Effects Model with Smoothing Splines
In this section, we apply the method of smoothing splines into the linear mixed-effect
model to fit the semiparametric linear mixed-effects model. ModelIV
Table 8: Semiparametric Mixed-Effects Model for SBP
Covariates for Model IV Coefficient P-value τ 2 σ2
Malperfusion 2.14 0.17
96.92 52.32
Preeclampsia 5.69 0.01
Race(black) 2.82 0.13
Age 0.15 0.30
BMI at Pregnancy 0.66 < 0.0001
Family History of Hypertension 0.36 0.82
Family History of Heart Disease 0.26 0.89
Table 9: Semiparametric Mixed-Effects Model for DBP
Covariates for Model IV Coefficient P-value τ 2 σ2
Malperfusion 3.08 0.02
69.66 15.92
Preeclampsia 2.87 0.10
Race(black) 2.54 0.10
Age 0.18 0.12
BMI at Pregnancy 0.48 < 0.0001
Family History of Hypertension 0.96 0.47
Family History of Heart Disease 2.20 0.16
The results from the smoothing splines is also quite similar with the estimate from
Model II and III. After adding the SS to adjust measurement time, women with placental
malperfusion are estimated to have 2.14 (95% CI [-0.94, 5.21]) and 3.08 (95% CI [0.59, 5.57])
mmhg higher SBP and DBP, respectively.
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4.0 Conclusions
From the results of the fitted model, we conclude that BMI at pregnancy was the most
significant predictor for BP 8-10 years after delivery in the window study. Considering both
statistical results and pathophysiology mechanism, even though placental malperfusion was
only statistically significant for DBP at the commonly used level of 0.05, the influence of
placental malperfusion should not be ignored to evaluate the risk of post-delivery CVD for
women.
Both NCS and SS provide powerful tools to adjust for the time trend of BP measurements
in our dataset. NCS is easier to fit and combine in the linear mixed-effects model. However,
NCS need to manually select knots or specify the degree of freedom, and one could get
different results with different settings in the NCS model.
Smoothing spline is a more general and flexible method. SS will fit in regards as all the
time points, thus no knots needs to be selected. It could fit more than the cubic polynomial
splines in NCS, and it could combine the smoothness penalty into a semiparametric linear
mixed-effect model to fit the data. However, this method is much more complicated than
NCS, and it is harder to implement in software and takes longer time to compute.
Based on the analytical results, we conclude that placental malperfusion is a prognostic
biomarker of DBP at about 8-10 years after delivery. “Preeclampsia” and “BMI at preg-
nancy” are very significant in our study, indicating that health provider should use these
clinical profiles to consider interventions to reduce the risk of hypertension and consequential
health impacts.
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Appendix
Example R Code
#Read in the c leaned d a t a s e t
data . o f f i c e<−read . csv ( ’ data o f f i c e order f i n a l 1 0 5 3 . csv ’ )
l ibrary ( lme4 )
l ibrary ( lmerTest )
#Model I
#Fi t model I f o r SBP
glm1 . s <− lmer ( sbp mmhg ˜ (1 | Window ID) , data=data . o f f i c e )
#Fit model I f o r DBP
glm1 . d <− lmer (dbp mmhg ˜ (1 | Window ID) , data=data . o f f i c e )
#Model I I
#Fi t m u l t i v a r i a t e model I I f o r SBP
glm2 . s<−lmer ( sbp mmhg ˜ malper fus ion + demorace +prepregbmi + age
+ preec lamps ia + famhbp
+famheart + (1 | Window ID) , data=data . o f f i c e )
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#Fit m u l t i v a r i a t e model I I f o r DBP
glm2 . d<−lmer (dbp mmhg ˜ malper fus ion + demorace +prepregbmi + age
+ preec lamps ia + famhbp
+famheart + (1 | Window ID) , data=data . o f f i c e )
#The code f o r m u l t i v a r i a t e model I I can be e a s i l y transformed f o r
f i t t i n g u n i v a r i a b l e model
#I I by changing the c o v a r i a t e s , f o r example , u n i v a r i a t e model f o r
SBP with malper fus ion
glm3 . s<−lmer ( sbp mmhg ˜ malper fus ion + (1 | Window ID) , data=data .
o f f i c e )
#Model I I I
l ibrary ( s p l i n e s )
l ibrary ( chron )#package to d e a l wi th time v a r i a b l e
#Fi t the n a t u r a l c u b i c s p l i n e s f o r SBP
z . s<−ns (data . o f f i c e $mean bp time ,
knots=chron : : t imes ( c ( ’ 0 8 : 51 : 40 ’ , ’ 1 0 : 20 : 00 ’ , ’ 1 2 : 02 : 00 ’ , ’
1 3 : 43 : 00 ’ ) ) ,
Boundary . knots = chron : : t imes ( c ( ’ 0 6 : 54 : 00 ’ , ’ 1 5 : 32 : 00 ’ ) ) )
NCS1<−lm( sbp mmhg ˜ z . s , data = data . o f f i c e )
#Fit the n a t u r a l c u b i c s p l i n e s f o r DBP
z . d<−ns (data . o f f i c e $mean bp time ,
knots=chron : : t imes ( c ( ’ 0 8 : 51 : 40 ’ , ’ 1 0 : 20 : 00 ’ , ’ 1 2 : 02 : 00 ’ , ’
1 3 : 43 : 00 ’ ) ) ,
Boundary . knots = chron : : t imes ( c ( ’ 0 6 : 54 : 00 ’ , ’ 1 5 : 32 : 00 ’ ) ) )
31
NCS1 . d<−lm(dbp mmhg ˜ z . s , data = data . o f f i c e )
#Fit model I I I f o r SBP
ncsglm1 . s<−lmer ( sbp mmhg ˜ malper fus ion + z . s + prepregbmi +
demorace +
preec lamps ia + age + famhbp + famheart + (1 | Window
ID) , data=data . o f f i c e )
#Fit model I I I f o r DBP
ncsglm1 . d<−lmer (dbp mmhg ˜ malper fus ion + z . d + prepregbmi +
demorace +
preec lamps ia + age + famhbp + famheart + (1 | Window
ID) , data=data . o f f i c e )
#Model IV
#The semiparametric mixed−e f f e c t s model ( slm ) f u n c t i o n i s b u i l t in
the package ” a s s i s t ”
l ibrary ( a s s i s t )
#Fit model IV f o r SBP
#data1 i s data . o f f i c e a f t e r e x c l u d i n g a l l miss ing v a l u e s because
slm () f u n c t i o n does not a l l o w
#miss ing v a l u e
slm1 . s<− slm ( sbp mmhg˜mean bp time + malper fus ion + demorace +
prepregbmi +
preec lamps ia + age + famhbp + famheart ,
rk=cubic ( chron : : t imes (mean bp time ) ) ,
random=l i s t (Window ID=˜1) , data=data1 )
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#Fit model IV f o r DBP
slm1 . d<− slm (dbp mmhg˜mean bp time + malper fus ion + demorace +
prepregbmi +
preec lamps ia + age + famhbp + famheart ,
rk=cubic ( chron : : t imes (mean bp time ) ) ,
random=l i s t (Window ID=˜1) , data=data1 )
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